193 related articles for article (PubMed ID: 34145665)
1. Live virus vaccination of pediatric solid organ transplant candidates within 1 month prior to transplantation: A multicenter experience.
Rosenthal A; Madigan T; Chen SF; Gans H; Nadimpalli S
Transpl Infect Dis; 2021 Aug; 23(4):e13667. PubMed ID: 34145665
[TBL] [Abstract][Full Text] [Related]
2. Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients.
Feldman AG; Beaty BL; Ferrolino JA; Maron G; Weidner HK; Ali SA; Bitterfeld L; Boulware MA; Campbell KM; Carr E; Chapman S; Chang YC; Cunningham R; Dallas RH; Dantuluri KL; Domenick BN; Ebel NH; Elisofon S; Fawaz R; Foca M; Gans HA; Gopalareddy VV; Gu C; Gupta NA; Harmann K; Hollenbeck J; Huppler AR; Jaramillo C; Kasi N; Kerkar N; Lerret S; Lobritto SJ; Lopez MJ; Marini E; Mavis A; Mehra S; Moats L; Mohandas S; Munoz FM; Mysore KR; Onsan C; Ovchinsky N; Perkins K; Postma S; Pratscher L; Rand EB; Rowe RK; Schultz D; Sear K; Sell ML; Sharma T; Stoll J; Vang M; Villarin D; Weaver C; Wood P; Woodford-Berry O; Yanni G; Danziger-Isakov LA
JAMA Netw Open; 2023 Oct; 6(10):e2337602. PubMed ID: 37824141
[TBL] [Abstract][Full Text] [Related]
3. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
Croce E; Hatz C; Jonker EF; Visser LG; Jaeger VK; Bühler S
Vaccine; 2017 Mar; 35(9):1216-1226. PubMed ID: 28162821
[TBL] [Abstract][Full Text] [Related]
4. Live-attenuated vaccination for measles, mumps, and rubella in pediatric liver transplantation.
Keutler A; Lainka E; Posovszky C
Pediatr Transplant; 2024 Feb; 28(1):e14687. PubMed ID: 38317348
[TBL] [Abstract][Full Text] [Related]
5. Measles, Mumps, Rubella, and Varicella Zoster Virus Serology and Infections in Solid Organ Transplant Recipients During the First Year Posttransplantation.
Rezahosseini O; Sørensen SS; Perch M; Ekenberg C; Møller DL; Knudsen AD; Kirkby N; Lundgren J; Lodding IP; Wareham NE; Gustafsson F; Rasmussen A; Nielsen SD
Clin Infect Dis; 2021 Dec; 73(11):e3733-e3739. PubMed ID: 32564061
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of Measles, Mumps, Rubella, and Varicella-Zoster Virus and Seroresponse to the Vaccinations in Adult Solid Organ Transplant Candidates.
Javaid H; Prasad P; De Golovine A; Hasbun R; Jyothula S; Machicao V; Bynon JS; Ostrosky L; Nigo M
Transplantation; 2023 Oct; 107(10):2279-2284. PubMed ID: 37309028
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.
Chong PP; Avery RK
Clin Ther; 2017 Aug; 39(8):1581-1598. PubMed ID: 28751095
[TBL] [Abstract][Full Text] [Related]
9. Serologic screening and infectious disease consultation (IDC): Indicated in heart, lung, liver (HLL) solid organ transplants (SOT) for measles, mumps, rubella, and varicella.
Seckin ZI; Brumble LM; Libertin CR
Transpl Infect Dis; 2020 Feb; 22(1):e13202. PubMed ID: 31647159
[TBL] [Abstract][Full Text] [Related]
10. Live vaccines after pediatric solid organ transplant: Proceedings of a consensus meeting, 2018.
Suresh S; Upton J; Green M; Pham-Huy A; Posfay-Barbe KM; Michaels MG; Top KA; Avitzur Y; Burton C; Chong PP; Danziger-Isakov L; Dipchand AI; Hébert D; Kumar D; Morris SK; Nalli N; Ng VL; Nicholas SK; Robinson JL; Solomon M; Tapiero B; Verma A; Walter JE; Allen UD
Pediatr Transplant; 2019 Nov; 23(7):e13571. PubMed ID: 31497926
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of measles, mumps, rubella and varicella live viral vaccines in transplant recipients receiving immunosuppressive drugs.
Danerseau AM; Robinson JL
World J Pediatr; 2008 Nov; 4(4):254-8. PubMed ID: 19104888
[TBL] [Abstract][Full Text] [Related]
12. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.
Nolan T; McIntyre P; Roberton D; Descamps D
Vaccine; 2002 Dec; 21(3-4):281-9. PubMed ID: 12450703
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
15. Serologic evaluation of vaccine preventable infections and vaccination rates in kidney transplant candidates.
Schneider S; Carlson A; Sirandas B; Clark B; Truax C
Transpl Infect Dis; 2022 Dec; 24(6):e13973. PubMed ID: 36263508
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
[TBL] [Abstract][Full Text] [Related]
17. [Vaccination].
Graubner UB; Liese J; Belohradsky BH
Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice.
Danziger-Isakov L; Kumar D;
Clin Transplant; 2019 Sep; 33(9):e13563. PubMed ID: 31002409
[TBL] [Abstract][Full Text] [Related]
19. [Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine].
Takayama N; Kidokoro M; Suzuki K; Morita M
Kansenshogaku Zasshi; 1992 Jun; 66(6):776-80. PubMed ID: 1331262
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of live attenuated varicella vaccine (Oka-RIT strain) and combined varicella and MMR vaccination in 13-17-month-old children.
Vesikari T; Ohrling A; Baer M; Delem A; Bogaerts H; André FE
Acta Paediatr Scand; 1991 Nov; 80(11):1051-7. PubMed ID: 1661057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
